Association studies of 5-HT2A and 5-HT2C serotonin receptor gene polymorphisms with prophylactic lithium response in bipolar patients

被引：0
|
作者：
Dmitrzak-Weglarz, M
Rybakowski, JK
Suwalska, A
Slopien, A
Czerski, PM
Leszczynska-Rodziewicz, A
Hauser, J
机构：
[1] Poznan Univ Med Sci, Lab Psychiat Genet, Dept Psychiat, PL-60572 Poznan, Poland
[2] Poznan Univ Med Sci, Dept Adult Psychiat, PL-60572 Poznan, Poland
[3] Poznan Univ Med Sci, Dept Child & Adolescent Psychiat, PL-60572 Poznan, Poland
来源：
PHARMACOLOGICAL REPORTS | 2005年 / 57卷 / 06期
关键词：
lithium prophylaxis; bipolar disorder; 5-HT2A; serotonin receptor 2A gene; 5-HT2C; serotonin receptor 2C gene; pharmacogenetics;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Lithium is one of the most commonly used drugs in the prophylaxis and treatment of bipolar disorder. The mechanisms of mood stabilization by lithium incorporate its effect. on serotonergic neurotransmission.' This paper investigates a relationship between response to lithium prophylaxis and polymorphisms in two genes: T102C of 5-HT2A receptor and G68C (Cys23Ser) of 5-HT2C serotonin receptor gene. Genotypes were estimated in 92 bipolar patients (39 males and 53 females) who have been taking lithium for at least 5 years. The patients were classified as excellent responders, partial responders and non-responders to lithium. The obtained results suggest that these polymorphisms may not be related to the degree of prophylactic lithium response.
引用
收藏
页码：761 / 765
页数：5
相关论文
共 50 条
  • [21] Simplified analogues of ritanserin and their affinity at 5-HT2A, 5-HT2B and 5-HT2C serotonin receptors
    Claudi, F
    Scoccia, L
    Giorgioni, G
    Marucci, G
    Di Stefano, A
    Gessi, S
    Siniscalchi, A
    Borea, PA
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1998, 33 (09) : 705 - 713
  • [22] No association between polymorphisms and the DRD2, MAQ-A, 5-HT2A, and 5-Ht2C genes and schizophrenia
    Li, S
    Breen, G
    Gu, NF
    Feng, GY
    Liu, WQ
    Bai, SC
    Zhang, JG
    Shen, T
    St Clair, D
    He, L
    MOLECULAR PSYCHIATRY, 1999, 4 : S113 - S113
  • [23] Association of Polymorphisms in 5-HT2A and 5-HT2C Receptors Genes With Depressive and Anxiety Disorders in Patients With Irritable Bowel Syndrome
    Mulak, Agata
    Waszczuk, Ewa
    Beszlej, Jan A.
    Szechinski, Marcin
    Frydecka, Dorota
    Szewczuk-Boguslawska, Monika
    Grzesiak, Magdalena
    GASTROENTEROLOGY, 2013, 144 (05) : S725 - S725
  • [24] Functional characteristics of serotonin 5-HT2A and 5-HT 2C receptors in the brain and the expression of the 5-HT2A and 5-HT2C receptor genes in aggressive and non-aggressive rats
    Popova N.K.
    Naumenko V.S.
    Kozhemyakina R.V.
    Plyusnina I.Z.
    Neuroscience and Behavioral Physiology, 2010, 40 (4) : 357 - 361
  • [25] The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins
    Bécamel, C
    Gavarini, S
    Chanrion, B
    Alonso, G
    Galéotti, N
    Dumuis, A
    Bockaert, J
    Marin, P
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (19) : 20257 - 20266
  • [26] Endogenous Serotonin 5-HT2A and 5-HT2C Receptors Associate in the Medial Prefrontal Cortex
    Price, Amanda E.
    Sholler, Dennis J.
    Stutz, Sonja J.
    Anastasio, Noelle C.
    Cunningham, Kathryn A.
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (07): : 3241 - 3248
  • [27] A comparison of the behavioural effects of 5-HT2A and 5-HT2C receptor agonists in the pigeon
    Wolff, MC
    Leander, JD
    BEHAVIOURAL PHARMACOLOGY, 2000, 11 (05): : 355 - 364
  • [28] Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors
    Aloyo, V. J.
    Berg, K. A.
    Spampinato, U.
    Clarke, W. P.
    Harvey, J. A.
    PHARMACOLOGY & THERAPEUTICS, 2009, 121 (02) : 160 - 173
  • [29] Exclusion of 5-HT2A and 5-HT2C receptor genes as candidate genes for migraine
    Buchwalder, A
    Welch, SK
    Peroutka, SJ
    HEADACHE, 1996, 36 (04): : 254 - 258
  • [30] Association study of serotonin 2A receptor (5-HT2A) and serotonin transporter (5-HTT) gene polymorphisms with schizophrenia
    Saiz, Pilar A.
    Garcia-Portilla, M. Paz
    Arango, Celso
    Morales, Blanca
    Alvarez, Victoria
    Coto, Eliecer
    Fernandez, Juan M.
    Bascaran, M. Teresa
    Bousono, Manuel
    Bobes, Julio
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2007, 31 (03): : 741 - 745
12345